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Hepatocellular carcinoma (HCC) is the fifth most 
common cancer and the second leading cause of 
cancer mortality worldwide.1,2  In general prognosis of 
HCC patient is poor, largely depending on the tumor 
stage, the severity of underlying liver disease, and 
treatment modalities. Patients with liver cirrhosis of 
any aetiology are known to be at increased risk for 
developing hepatocellular carcinoma (HCC).1,3 Chronic 
infection with hepatitis B and C virus are one of the 
high risk condition to develop HCC.4-6  Diagnosis of this 
condition is often delayed because no obvious sign or 
symptom and get noticed till the tumour has become 
fairly large. Hence, in a majority of symptomatic 
patients diagnosed with HCC, no effective treatment 
is possible and survival is short.7 
World Health Organization (WHO) fact sheet in 
2017 stated that 30-50% of cancer, including HCC 
can be prevented.2 In this sense, surveillance of HCC 
is important part of the management of chronic liver 
disease patients.8,9 There are few method of HCC 
surveillance and the most widely use is to perform 
ultrasonography (US) and AFP every 6 months.8 
Indonesian Asscociation of Study of the Liver (Ina-
ASL) use the same strategy in HCC surveilance.9 Asia 
Pacific Association for Study of the Liver (APASL) 
sugested the use of other PIVKA-II along with AFP 
but in Indonesia this test is not yet available. It was 
estimated that surveillance using AFP and US at 
6-month intervals would nearly halve the number of 
HCC-related deaths. 
In the current journal, Putra AP et al describe HCC 
surveillance in national tertiary referral hospital, Cipto 
Mangunkusumo.10 They revealed that from 200 liver 
cirrhosis patients, 25% of them have been in the HCC 
surveillance. Ideally all of the cirrhosis patients should 
be in active surveillance and in their study, only 16.5% 
in active surveillance. Active surveillance is crucial to 
make an early diagnosis of HCC because liver cirrhosis 
condition is high risk for HCC. 
Factors that associated with HCC surveillance in 
their study were HCC education and liver cirrhosis 
condition. Patients with worsen liver cirrhosis 
condition tend to comply better to HCC surveillance 
compare to patients who has a good liver function. 
Higher proportion of HCC surveillance was found 
in patients who received sufficient education about 
HCC. This data support the previous report by Singa 
et al that a significant number of patients who undergo 
HCC surveillance were found in group with adequate 
education from gastroenterohepatologist.11 Qualitative 
review by Jin et al from 102 studies revealed that lack 
of routine surveillance was caused by insufficient 
education about their disease, prevention plan, and 
therapy.12 Patients did not know the risk and benefit 
from routine HCC surveillance or they thought that 
their disease can be cured in one time visit to the doctor 
without further evaluation. Hence, education for the 
patient is a very important part to improve overall HCC 
surveillance compliance and must be integrated in the 
whole HCC management.
Patient education itself is the process of enabling 
individuals to make informed decisions about their 
personal health-related behaviour.13 A successful 
behavioural change will improve patient compliance 
to the treatment. Several theories underlying health-
related behavior have been proposed to help us make 
educational intervention: (1) Self-efficacy, learned 
helplessness and attribution theory: Self-efficacy is 
one’s own belief in one’s ability to cope with certain 
stresses. It suggests that whether one is able to achieve 
something is strongly dependent on whether one 
believes one can do it (Bandura 1977).14 For example, a 
patient believes that he/she can give up smoking, then 
they are more likely to succeed giving up smoking. 
Learned helplessness is essentially having very low 
self-efficacy, where one believes that one’s own actions 
will not have any effect on the outcome of an event 
(Seligman & Maier, 1967; Seligman, 1975).15 For 
example patient with heart attack history wont give up 
smoking because he thought that he will die eventually. 
Attribution theory recognizes that self-efficacy and 
learned helplessness are not fixed aspects of personality 
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(Lewis & Daltroy, 1990);16 (2) Fear arousal and coping 
theory: Leventhal (1971) hypothesized that fear is a 
prime motivator of behaviour.17 Exposure of fear will 
change their behaviour to take action that can reduce 
fear. For example patient with heart attack history 
should stop smoking or he/she will be at risk of death; 
(3) Social learning theory: This theory suggest that 
spcial interactions influence one behavioiur in some 
way. Rotter (1954) hypothesized that our behaviour 
is influenced by observing the actions of others. 
Positive or negative reinforcement of behaviour occurs 
depending on the outcome of the observed actions.18 
Based on the theories shown before, there are 2 
models of health behavior: (1) PRECEDE model 
(Green et al., 1975; Green, 1979; 1999):19 This model 
asses the patient’s readiness for behavioural change 
in 3 phases. 1) predisposing factors, patients believe 
that their disease will be worsen without enough 
compliance; 2) enabling factors, patient’s must have 
enough skill and resources; 3) reinforcing factors, 
patients must believe that this intervention is realistic 
and can improve their health. They need to fulfill each 
phase requirement before moving to the next phase; (2) 
Health belief model: Health belief model depends on 
individual perception, modifying factor and likelihood 
of action. Educational models based on behavioral 
theory can help us to understand patients’ actions and 
to plan effective educational interventions.
An understanding regarding these educational 
theories will assist healthcare provider in daily basis. 
Doctor can not be the only person responsible for 
patient education for HCC and for that reason health 
personnel such as nurse, laboratory technician, 
nutritionist must help to educate the patient effectively. 
Moreover, there should be a clinical manager that 
evaluate whether the patient comply enough to the 
treatment plan or lost on follow-up. The whole program 
will be a system that improve patient compliance to 
the process of HCC surveillance. 
Many studies suggest that patients with cirrhosis 
lack the knowledge to effectively manage their disease. 
The introduction of a leaflet resulted in a statistically 
significant improvement in understanding.20 It seems 
that a patient information leaflet might offer a cost-
effective and simple method to improve knowledge 
despite its small size and limited follow-up period in 
the study. Longitudinal studies are required to confirm 
whether this intervention can make improvement in 
overall disease outcome. 
The use of modern technology such as multimedia 
can also improve the understanding of liver cirrhosis 
and its complication. Multimedia education is a recent 
effective method to improve patients understanding 
of liver disease.21 When education was delivered by 
screencast, a large increase in knowledge questionnaire 
scores was observed at one month interval follow 
up. This suggests that this form of education enabled 
sustained retention of the knowledge. This method 
can also be easily adopted in many centres and used 
in wide range of other diseases.
Holistic management in cirrhosis and HCC will 
still become challenging issues for the next couple 
years. Patient education regarding HCC surveillance 
should be included in the management of liver cirrhosis 
patients as a whole. Education about liver cirrhosis 
patient should include understanding about how 
their liver can be damage by long standing process in 
chronic liver disease and unnoticed because no obvious 
symptoms or signs. Understanding theories underlying 
health-related behavior and health education model 
can help us to make effective educational intervention. 
Given the rising prevalence of cirrhosis and HCC, 
the necessity for a more holistic approach to the 
management of liver disease will become inevitable. 
HCC surveillance must be done for all liver 
cirrhosis patients to find early liver cancer. Also to 
avoid complications of decline liver function which can 
put the patient into a difficult situation if liver cancer 
should be treated. The most reliable factor for HCC 
surveillance is to educate the patients on the importance 
of the program and how the program can help them to 
achieve longer survival.
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